Next Quarterly Earnings
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Insmed Incorporated is a global US-based biopharmaceutical company dedicated to developing and commercializing innovative medicines for patients with rare and severe diseases. Its portfolio features treatments for specific lung diseases and neuromuscular disorders, addressing significant unmet medical needs.
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Insmed Incorporated is scheduled to report its next quarterly earnings on 10/22/2026. Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Insmed Incorporated last reported quarterly earnings on 8/6/2026 (Q2 2026). Earnings per share (EPS) came in at -0.06 USD.
Across its last 3 earnings reports, Insmed Incorporated stock moved by ±15.4% on average the following day. The largest reaction was -23.4% on 05/07/2026; 2 of 3 reactions were positive.
Insmed Incorporated has beaten analyst EPS estimates in 2 of its last 5 evaluated quarters (beat rate: 40%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 3 report dates (close to close).
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.